Using Aran’s Knowhow to create advanced
medical devices
We recognize the value of the entrepreneurial spirit that motivates people to pursue a dream. That’s why we initiate and invest in our own medical startups focusing on Cardiovascular, Laparoscopy and Gastrointestinal endoscopy.
In all our innovations, we harness our own resources and experience in carrying out a lean, ultra-efficient product development process, with an ambitiously low budget and short timetables.
Our work is backed by our experienced medical R&D team, our thorough understanding of the regulatory issues, our verification and validation (V&V) testing capabilities and our pre-clinical and clinical experience.
Recent Exits
Four of our successful medical device venture spinoffs have been acquired by large multinational corporations and we are currently involved in the development and commercialization of several other medical device enterprises.
Percutaneous heart valve
Established: 2002
Name of company: PVT
Ownership: 14% ARAN; 86% American and French entrepreneurs
Acquired by: Edwards Lifesciences
Year of acquisition: 2004
Sold for: $150 million
Mitral valve
Established: 2005
Name of project: Mitria
Ownership: 75% ARAN; 25% additional investors
Acquired by: Edwards Lifesciences
Year of acquisition: 2005
Sold for: $1.2 million
SPOT™ Reentry Balloon Catheter
Established: 2008
Name of company: S.I. Therapies
Ownership: 56% ARAN; 44% additional investors
Acquired by: Boston Scientific
Year of acquisition: 2010
Sold for: $29 million
Tool for opening of clogged blood vessels
Established: 2011
Name of company: Upstream Peripheral Technologies
Ownership: 58% ARAN; 42% additional investors
Acquired by: Spectranetics
Year of acquisition: 2013
Sold for: $35.5 million
Current Projects
GoBack™ Catheter
Established: 2016
Name of company: Upstream Peripheral Technologies
Ownership: 69% ARAN; 31% additional investors
Endoaid Ltd.
Established: 2013
Ownership: 66% ARAN; 34% additional investors
